# Rozlytrek

NDC: 50242-623
Generic name: ENTRECTINIB
Labeler / Manufacturer: Genentech, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: PELLET
Routes: ORAL
Marketing started: 20231020

FDA application: NDA218550

## Active ingredients

- ENTRECTINIB: 50 mg/201

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50242-623"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50242-623
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c7c71b0c-2549-4495-86b6-c2807fa54908